RETRACTED ARTICLE: Amphiregulin enhances cardiac fibrosis and aggravates cardiac dysfunction in mice with experimental myocardial infarction partly through activating EGFR-dependent pathway
Authors:
- 18 January 2018
- journal article
- retracted article
- Published by Springer Nature in Basic Research in Cardiology
- Vol. 113 (2) , 12
Abstract
Cardiac fibrosis (CF), a main process of ventricular remodeling after myocardial infarction (MI), plays a crucial role in the pathogenesis of heart failure (HF) post-MI. It is known that amphiregulin (AR) is involved in fibrosis of several organs. However, the expression of AR and its role post-MI are yet to be determined. This study aimed to investigate the impact of AR on CF post-MI and related mechanisms. Significantly upregulated AR expression was evidenced in the infarct border zone of MI mice in vivo and the AR secretion was enhanced in macrophages, but not in cardiac fibroblasts. In vitro, treatment with AR increased cardiac fibroblast migration, proliferation and collagen synthesis, and upregulated the expression of epidermal growth factor receptor (EGFR) and the downstream genes such as Akt, ERK1/2 and Samd2/3 on cardiac fibroblasts. All these effects could be abrogated by pretreatment with a specific EGFR inhibitor. To verify the functions of AR in MI hearts, lentivirus–AR–shRNA and negative control vectors were delivered into the infarct border zone. After 28 days, knock-down of AR increased the survival rate and improved cardiac function, while decreasing the extent of myocardial fibrosis of MI mice. Moreover, EGFR and the downstream genes were significantly downregulated in lentivirus–AR–shRNA treated MI mice. Our results thus indicate that AR plays an important role in promoting CF after MI partly though activating the EGFR pathway. Targeting AR might be a novel therapeutic option for attenuating CF and improve cardiac function after MI.Keywords
Funding Information
- National Natural Science Foundation of China (81470470)
- National Natural Science Foundation of China (81670321)
This publication has 47 references indexed in Scilit:
- Bone Marrow CD11c+ Cell–Derived Amphiregulin Promotes Pulmonary FibrosisThe Journal of Immunology, 2016
- A Distinct Function of Regulatory T Cells in Tissue ProtectionCell, 2015
- The war against heart failure: the Lancet lectureThe Lancet, 2015
- A Special Population of Regulatory T Cells Potentiates Muscle RepairCell, 2013
- Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinomaHepatology, 2013
- The multiple roles of amphiregulin in human cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2011
- Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR‐dependent signalingJournal of Cellular Biochemistry, 2010
- Mesenchymal stem cell injection after myocardial infarction improves myocardial complianceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- Structural Basis for Heart FailureCirculation, 1995